BioCentury
ARTICLE | Company News

Caliber Biotherapeutics, iBio deal

February 25, 2013 8:00 AM UTC

iBio granted Caliber a non-exclusive license to use iBio's iBioLaunch plant-based vaccine and therapeutic protein manufacturing platform to develop and commercialize biopharmaceuticals against targets...